https://endpoints.news/kallyope-heads-to-phase-3-with-migraine-drug-after-mid-stage-success/
Kallyope heads to Phase 3 with migraine drug after mid-stage success
Dec 8, 2025 - Kallyope said that its experimental migraine drug elismetrep succeeded in a Phase 2b trial that measured patients' pain two hours after taking the pill.
migraine drugkallyopeheadsmid
https://endpoints.news/kallyope-scraps-one-of-two-mid-stage-migraine-drugs/
Kallyope scraps one of two mid-stage migraine drugs
Nov 26, 2025 - Kallyope terminates Phase 2a trial of migraine drug K-645 to focus on elismetrep and metabolic portfolio. Company previously faced setback with obesity drug in...
mid stagekallyopescrapsonetwo